Edition:
United States

Brainstorm Cell Therapuetics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

3.11USD
3:59pm EST
Change (% chg)

$-0.01 (-0.32%)
Prev Close
$3.12
Open
$3.12
Day's High
$3.20
Day's Low
$3.00
Volume
7,999
Avg. Vol
15,999
52-wk High
$5.15
52-wk Low
$2.88

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.128
Jun '17 0.00 -0.056
Mar '17 0.00 -0.096
FY 2016 Dec '16 0.00 -0.033
Sep '16 0.00 -0.086
Jun '16 0.00 -0.052
Mar '16 0.00 -0.096
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Earnings (per share)
Quarter Ending Mar-18 1 -0.32 -0.32 -0.32 -0.26
Quarter Ending Jun-18 1 -0.28 -0.28 -0.28 -0.24
Year Ending Dec-18 1 -1.18 -1.18 -1.18 -1.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 189.80 34.75
P/E High - Last 5 Yrs. -- 284.12 46.00
P/E Low - Last 5 Yrs. -- 92.89 24.22
Beta 1.37 0.81 0.81
Price to Sales (TTM) -- 135.24 8.23
Price to Book (MRQ) 11.46 20.37 5.26
Price to Tangible Book (MRQ) 11.46 28.60 6.43
Price to Cash Flow (TTM) -- 126.27 26.16
% Owned Institutions 9.71 11.97 2.26

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.51
Dividend Yield - 5 Year Avg -- 0.20 2.02
Dividend 5 Year Growth Rate -- 1.92 5.22
Payout Ratio(TTM) -- 8.39 43.43

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 63.69 9.79
Sales (TTM) vs TTM 1 Yr. Ago -- 63.80 7.60
Sales - 5 Yr. Growth Rate -- 33.26 10.22
EPS (MRQ) vs Qtr. 1 Yr. Ago -48.99 -99.96 17.74
EPS (TTM) vs TTM 1 Yr. Ago -1.45 -- --
EPS - 5 Yr. Growth Rate -- 46.90 11.61
Capital Spending - 5 Yr. Growth Rate 16.50 42.29 14.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.43
Current Ratio (MRQ) 1.78 5.76 3.39
LT Debt to Equity (MRQ) 0.00 16.49 12.05
Total Debt to Equity (MRQ) 0.00 18.61 15.44
Interest Coverage (TTM) -- -166.79 38.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.28 54.71
Gross Margin - 5 Yr. Avg. -- 55.52 52.58
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -236.98 14.67
Operating Margin (TTM) -- -474.87 4.61
Operating Margin - 5 Yr. Avg. -- -253.74 9.99
Pre-Tax Margin (TTM) -- -449.94 5.35
Pre-Tax Margin - 5 Yr. Avg. -- -260.30 10.27
Net Profit Margin (TTM) -- -445.34 1.86
Net Profit Margin - 5 Yr. Avg. -- -263.73 6.57
Effective Tax Rate (TTM) -- 0.42 21.98
Effective Tax Rate - 5 Yr. Avg. -- 18.01 24.18

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,891,213 828,235,197
Net Income/Employee (TTM) -- -630,600 96,880,046
Receivable Turnover (TTM) -- 14.32 5.42
Inventory Turnover (TTM) -- 2.43 3.50
Asset Turnover (TTM) 0.00 0.39 0.91

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -50.76 -1.01 10.70
Return on Assets - 5 Yr. Avg. -71.19 -0.24 12.05
Return on Investment (TTM) -74.44 -0.65 13.63
Return on Investment - 5 Yr. Avg. -91.15 2.39 15.78
Return on Equity (TTM) -74.44 -3.21 15.25
Return on Equity - 5 Yr. Avg. -93.46 -1.55 17.01
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 42.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Brainstorm Cell Therapuetics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 9.71%
# of Holders: 41
Total Shares Held: 1,829,506
3 Mo. Net Change: 188,819
# New Positions: 8
# Closed Positions: 5
# Increased Positions: 21
# Reduced Positions: 8
# Net Buyers: 13
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.